fluocinolone acetonide has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, C; Campochiaro, PA; Chakravarthy, U; Cunha-Vaz, J; Green, K; Wykoff, CC | 1 |
| Arcinue, CA; Cerón, OM; Foster, CS | 1 |
1 trial(s) available for fluocinolone acetonide and Disease Exacerbation
| Article | Year |
|---|---|
Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy.
Topics: Adult; Aged; Diabetic Retinopathy; Disease Progression; Drug Implants; Female; Fluocinolone Acetonide; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Visual Acuity; Vitrectomy | 2017 |
1 other study(ies) available for fluocinolone acetonide and Disease Exacerbation
| Article | Year |
|---|---|
A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cataract; Dexamethasone; Disease Progression; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Retrospective Studies; Secondary Prevention; Time Factors; Treatment Outcome; Uveitis; Visual Acuity | 2013 |